Skip to search formSkip to main contentSkip to account menu

Baypamun HK

Known as: Baypamun 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Viral Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
The use of immunomodulators in the control of infectious bovine rhinotracheitis.
2000
2000
Effect of Baypamun on blood leucocytes in normal and dexamathasone treated goats.
The aim of this study was to determine the effect of Baypamun on selected lymphocyte subpopulations and granulocyte phagocytic… 
1999
1999
Treatment of feline leukemia virus (FeLV) infection.
1998
1998
Treatment of feline leukemia virus-infected cats with paramunity inducer.
1998
1998
Further investigations on the efficacy of a non-specific defence inducer evaluated in calves exposed to infectious bovine rhinotracheitis virus.
1997
1997
[The therapy of equine sarcoid with a non-specific immunostimulator--the epidemiology and spontaneous regression of sarcoids].
20 sarcoid-affected horses from a practice in the northern Jura were used in this experiment. The mean age of the 20 horses was 3… 
1996
1996
A non-specific defence inducer in preventing clinical signs of infectious bovine rhinotracheitis in calves.
1996
1996
Furunculosis control using a paraimmunization stimulant (Baypamun) in rainbow trout.
The effect of Baypamun, a non-specific immune system stimulant, on the treatment and control of furunculosis was studied in… 
1995
1995
The use of a non-specific defence mechanism inducer in calves exposed to bovine herpesvirus-1 infection: preliminary trials.
1989
1989
[The effectiveness of the paramunity inducer Baypamun (PIND-ORF) for the prevention and metaphylaxis of an experimental infection with the infectious bovine rhinotracheitis virus in cattle].
Efficacy of the paramunity inducer Baypamun (PIND-ORF) was evaluated by an IBR challenge trial in cattle, as one model for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)